Certifications, hospital deployments, international expansion and the events where we show CarnaLife Holo — everything happening at MedApp.
MedApp's augmented reality and AI-based solutions can support physicians in military hospitals and in operational conditions. The company holds an NCAGE code, and its subsidiary has applied for a licence to trade in military-purpose technology.
Read moreThe Management Board informs about actions taken by the Social Insurance Institution (ZUS) regarding the Issuer's liabilities and the application submitted to pay the amounts due in instalments. Maintaining operational continuity remains the priority.
Read moreOn 27–30 October 2025 MedApp presents CarnaLife Holo at the Global Health Exhibition in Riyadh – one of the largest healthcare events in the world. Find us in Hall H1A, stand PODS64.
Read moreThe VR Health Champions Open Call 2025 is accepting applications from European SMEs working on breakthrough XR healthcare solutions. Selected participants will receive up to EUR 40,000 in funding.
Read moreMaciej Stanuch, CarnaLife Holo Technology Manager at MedApp S.A., took part in the panel “European Entrepreneurial Region: how do Małopolska's start-ups implement the innovative solutions of the future?” at Krynica Forum 2024.
Read morePhysicians at the Bieganski Hospital in Łódź are using CarnaLife Holo to better interpret patients' diagnostic data – improving the quality of treatment and shortening procedure times.
Read moreA few months after receiving FDA clearance, CarnaLife Holo was spotlighted by the influential US portal CardiovascularBusiness.com in the context of its integration with GE HealthCare echocardiographs.
Read moreCarnaLife Holo and CarnaLife System have been awarded MDR (Medical Device Regulation) certification by TÜV NORD – confirmation of the highest standards of quality and safety and a gateway to further international markets.
Read moreAt the University Dental Centre of the Medical University of Silesia, a team led by Professor Małgorzata Skucha-Nowak performed the first dental procedures supported by CarnaLife Holo 3D holographic imaging in HoloLens 2.
Read moreMedApp is extending its business into dentistry, bringing 3D/4D imaging technologies to dental practices to support clinicians during complex procedures.
Read moreJoining the NVIDIA Developer Program strengthens MedApp's ability to build GPU-accelerated applications and deepens its existing partnership with NVIDIA, under which the company is a member of the NVIDIA Inception programme.
Read moreIn an interview with ISBnews, CEO David Odrakiewicz discusses the opportunity created by the multi-billion KPO outlay on hospital modernisation, the new dental segment and plans for another FDA submission.
Read moreMedApp has signed a funding agreement for the “We Are Health Champions” project worth EUR 7.88 million, implemented under the EU I3 instrument together with 17 partners from across Europe.
Read moreMedApp USA Inc. has been formed, headquartered in Dover, Delaware, with an operating office at the GuideWell Innovation Center in Orlando – part of Medical City in Lake Nona. Habeel Gazi has been appointed Managing Director.
Read moreFollowing a successful HIMSS24, MedApp is ready for the next step towards the US market – establishing a subsidiary in the United States to respond effectively to the needs of American partners and customers.
Read moreDoktor Guzik Fundacja Rodzinna has acquired 51.81% of MedApp S.A. shares, while Amida Capital and Blue Ring have sold their entire holdings. The new shareholder fully supports the company's foreign expansion strategy.
Read moreA report from HIMSS24 in Orlando: dozens of meetings with physicians, investors and distributors, and the FDA clearance that set CarnaLife Holo apart from the solutions on show.
Read moreMedApp will present CarnaLife Holo at HIMSS24 – one of the largest medical technology trade shows in the world, held on 11–15 March 2024 in Orlando, Florida.
Read moreIn 2023 MedApp Clinics integrated with five renowned medical facilities, began cooperating with Medfile and signed a letter of intent with the hospital in Grodzisk Wielkopolski.
Read moreAt the final of the 33rd “Teraz Polska” competition held at the National Philharmonic in Warsaw, CarnaLife Holo by MedApp received the “Teraz Polska” Emblem in the innovative ventures category.
Read moreCarnaLife Holo – MedApp's technology for augmented reality imaging of medical data – has received FDA 510(k) Class II clearance, opening the way to the largest medical market in the world.
Read moreOn 28 March 2023 MedApp was admitted to the community of the LifeScience Kraków Cluster, a National Key Cluster developing the life science innovation ecosystem in southern Poland.
Read moreIn the fourth quarter of 2022 MedApp recorded PLN 1,026 thousand in sales revenue, PLN 513 thousand in EBITDA and PLN 480 thousand in net profit, signed further CarnaLife Holo distribution agreements and established MedApp RT.
Read moreMedApp S.A.'s current and periodic reports are published in the investor section.
